vs

Side-by-side financial comparison of Alector, Inc. (ALEC) and CaliberCos Inc. (CWD). Click either name above to swap in a different company.

Alector, Inc. is the larger business by last-quarter revenue ($6.2M vs $4.1M, roughly 1.5× CaliberCos Inc.). On growth, CaliberCos Inc. posted the faster year-over-year revenue change (-52.5% vs -88.5%). Over the past eight quarters, Alector, Inc.'s revenue compounded faster (-37.4% CAGR vs -57.6%).

Alector, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative immunotherapies for neurodegenerative diseases. Its product pipeline targets unmet medical needs including Alzheimer’s disease, frontotemporal dementia, and Parkinson’s disease, and it collaborates with global pharmaceutical partners to advance candidate therapies through clinical trials.

CaliberCos Inc. is a U.S.-headquartered alternative asset management firm focused primarily on real estate investments. It offers a diverse suite of investment vehicles covering commercial, residential, and industrial real estate assets, serving institutional investors, high-net-worth individuals, and retail clients across North America. It also delivers asset management, property operation, and value-add real estate development services to support consistent long-term returns for investors.

ALEC vs CWD — Head-to-Head

Bigger by revenue
ALEC
ALEC
1.5× larger
ALEC
$6.2M
$4.1M
CWD
Growing faster (revenue YoY)
CWD
CWD
+36.0% gap
CWD
-52.5%
-88.5%
ALEC
Faster 2-yr revenue CAGR
ALEC
ALEC
Annualised
ALEC
-37.4%
-57.6%
CWD

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ALEC
ALEC
CWD
CWD
Revenue
$6.2M
$4.1M
Net Profit
$-7.7M
Gross Margin
Operating Margin
-196.6%
Net Margin
-188.3%
Revenue YoY
-88.5%
-52.5%
Net Profit YoY
-1696.9%
32.2%
EPS (diluted)
$1.95

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ALEC
ALEC
CWD
CWD
Q4 25
$6.2M
$4.1M
Q3 25
$3.3M
$3.6M
Q2 25
$7.9M
$5.1M
Q1 25
$3.7M
$7.3M
Q4 24
$54.2M
$8.7M
Q3 24
$15.3M
$11.3M
Q2 24
$15.1M
$8.2M
Q1 24
$15.9M
$23.0M
Net Profit
ALEC
ALEC
CWD
CWD
Q4 25
$-7.7M
Q3 25
$-34.7M
$-4.4M
Q2 25
$-30.5M
$-5.3M
Q1 25
$-40.5M
$-4.4M
Q4 24
$-2.1M
$-11.4M
Q3 24
$-42.2M
$146.0K
Q2 24
$-38.7M
$-4.7M
Q1 24
$-36.1M
$-3.8M
Operating Margin
ALEC
ALEC
CWD
CWD
Q4 25
-196.6%
Q3 25
-1153.6%
-129.6%
Q2 25
-433.6%
-112.4%
Q1 25
-1216.5%
-62.7%
Q4 24
-13.4%
-236.8%
Q3 24
-315.7%
0.0%
Q2 24
-302.4%
-65.0%
Q1 24
-275.0%
-22.9%
Net Margin
ALEC
ALEC
CWD
CWD
Q4 25
-188.3%
Q3 25
-1063.4%
-120.2%
Q2 25
-387.7%
-104.5%
Q1 25
-1101.6%
-60.7%
Q4 24
-3.8%
-247.6%
Q3 24
-275.2%
1.3%
Q2 24
-256.4%
-57.8%
Q1 24
-227.0%
-16.6%
EPS (diluted)
ALEC
ALEC
CWD
CWD
Q4 25
$1.95
Q3 25
$-0.34
$-1.65
Q2 25
$-0.30
$-4.15
Q1 25
$-0.41
$-3.85
Q4 24
$-0.02
$-10.15
Q3 24
$-0.43
$0.12
Q2 24
$-0.40
$-4.34
Q1 24
$-0.38
$-3.53

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ALEC
ALEC
CWD
CWD
Cash + ST InvestmentsLiquidity on hand
$256.0M
$2.9M
Total DebtLower is stronger
$10.0M
Stockholders' EquityBook value
$30.6M
$1.3M
Total Assets
$293.2M
$135.4M
Debt / EquityLower = less leverage
0.33×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ALEC
ALEC
CWD
CWD
Q4 25
$256.0M
$2.9M
Q3 25
$291.1M
$10.9M
Q2 25
$307.3M
$683.0K
Q1 25
$354.6M
$1.6M
Q4 24
$413.4M
$2.3M
Q3 24
$457.2M
$1.6M
Q2 24
$503.3M
$1.8M
Q1 24
$562.1M
$2.1M
Total Debt
ALEC
ALEC
CWD
CWD
Q4 25
$10.0M
Q3 25
Q2 25
Q1 25
Q4 24
$10.0M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
ALEC
ALEC
CWD
CWD
Q4 25
$30.6M
$1.3M
Q3 25
$57.7M
$4.2M
Q2 25
$71.2M
$-19.9M
Q1 25
$94.6M
$-15.8M
Q4 24
$126.8M
$-12.6M
Q3 24
$118.9M
$-3.8M
Q2 24
$150.6M
$-4.7M
Q1 24
$178.9M
$-745.0K
Total Assets
ALEC
ALEC
CWD
CWD
Q4 25
$293.2M
$135.4M
Q3 25
$335.3M
$82.6M
Q2 25
$356.4M
$59.3M
Q1 25
$408.3M
$103.6M
Q4 24
$468.3M
$105.5M
Q3 24
$516.0M
$158.6M
Q2 24
$570.7M
$195.2M
Q1 24
$635.5M
$201.5M
Debt / Equity
ALEC
ALEC
CWD
CWD
Q4 25
0.33×
Q3 25
Q2 25
Q1 25
Q4 24
0.08×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ALEC
ALEC
CWD
CWD
Operating Cash FlowLast quarter
$-184.0M
$-12.1M
Free Cash FlowOCF − Capex
$-184.1M
FCF MarginFCF / Revenue
-2951.3%
Capex IntensityCapex / Revenue
0.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-326.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ALEC
ALEC
CWD
CWD
Q4 25
$-184.0M
$-12.1M
Q3 25
$-32.5M
$-4.6M
Q2 25
$-49.0M
$-1.2M
Q1 25
$-60.8M
$-1.7M
Q4 24
$-55.0M
$555.0K
Q3 24
$-50.7M
$-74.0K
Q2 24
$-62.8M
$1.4M
Q1 24
$-61.3M
$-1.5M
Free Cash Flow
ALEC
ALEC
CWD
CWD
Q4 25
$-184.1M
Q3 25
$-32.5M
Q2 25
$-49.1M
Q1 25
$-60.8M
Q4 24
$-55.2M
Q3 24
$-50.9M
Q2 24
$-63.1M
Q1 24
$-61.9M
FCF Margin
ALEC
ALEC
CWD
CWD
Q4 25
-2951.3%
Q3 25
-997.6%
Q2 25
-623.0%
Q1 25
-1655.0%
Q4 24
-101.8%
Q3 24
-332.1%
Q2 24
-418.6%
Q1 24
-389.3%
Capex Intensity
ALEC
ALEC
CWD
CWD
Q4 25
0.7%
Q3 25
0.3%
Q2 25
0.1%
Q1 25
0.5%
Q4 24
0.3%
Q3 24
1.4%
Q2 24
2.2%
Q1 24
3.4%
Cash Conversion
ALEC
ALEC
CWD
CWD
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
-0.51×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons